Meet the Novel Players in Hypertensive Kidney Disease: Septin4 and SIRT2
Author:
Affiliation:
1. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Reference15 articles.
1. Centers for Disease Control and Prevention. Hypertension cascade: hypertension prevalence treatment and control estimates among U.S. Adults aged 18 years and older applying the criteria from the american college of cardiology and American heart association’s 2017 hypertension guideline—NHANES 2015–2018. Atlanta GA: U.S. Department of health and human services; 2021. Accessed March 12 2021. https://millionhearts.hhs.gov/data-reports/hypertension-prevalence.html
2. Prevention CfDCa. Chronic kidney disease in the United States 2021. Services UDoHaH; 2021. https://www.cdc.gov/kidneydisease/publications-resources/CKD-national-facts.html
3. Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease
4. Deacetylation of Septin4 by SIRT2 (Silent Mating Type Information Regulation 2 Homolog-2) Mitigates Damaging of Hypertensive Nephropathy
5. Septin4 as an autophagy modulator regulates Angiotensin-II mediated VSMCs proliferation and migration
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3